These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3926648)

  • 1. Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons.
    Wilson CB; Westall J
    Infect Immun; 1985 Aug; 49(2):351-6. PubMed ID: 3926648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of murine macrophages and a bovine monocyte cell line by bovine lymphokines to kill the intracellular pathogens Eimeria bovis and Toxoplasma gondii.
    Hughes HP; Speer CA; Kyle JE; Dubey JP
    Infect Immun; 1987 Mar; 55(3):784-91. PubMed ID: 3102381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular defenses against Toxoplasma gondii in newborns.
    Wilson CB; Haas JE
    J Clin Invest; 1984 Jun; 73(6):1606-16. PubMed ID: 6327765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human monocyte-derived macrophages cultured on Teflon: response to interferon-gamma during terminal maturation in vitro.
    Andreesen R; Gadd S; Brugger W; Löhr GW; Atkins RC
    Immunobiology; 1988 May; 177(2):186-98. PubMed ID: 3136081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism.
    Andrade RM; Wessendarp M; Subauste CS
    J Immunol; 2003 Dec; 171(12):6750-6. PubMed ID: 14662879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha.
    Beaman MH; Hunter CA; Remington JS
    J Immunol; 1994 Nov; 153(10):4583-7. PubMed ID: 7963530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD; Bottomly K
    J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
    Black CM; Catterall JR; Remington JS
    J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens.
    Black CM; Bermudez LE; Young LS; Remington JS
    J Exp Med; 1990 Sep; 172(3):977-80. PubMed ID: 2117640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal macrophages from C57BL/6 mice orally immunized with Toxoplasma gondii antigens in association with cholera toxin possess an enhanced ability to inhibit parasite multiplication.
    Bourguin I; Chardès T; Bout D
    FEMS Immunol Med Microbiol; 1995 Oct; 12(2):121-6. PubMed ID: 8589661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
    Tomioka H; Maw WW; Sato K; Saito H
    Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of 'macrophage' function. VI. Down-regulation for Ia-expression of newborn mouse macrophages by endogenous beta-interferon.
    Kitaura M; Kato T; Inaba K; Watanabe Y; Kawade Y; Muramatsu S
    Dev Comp Immunol; 1988; 12(3):645-55. PubMed ID: 3139475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for involvement of TNF-alpha in the induction phase and IFN-beta in the effector phase of antiproliferative activity of splenic macrophages.
    Stout RD; Suttles J
    Cell Immunol; 1992 Feb; 139(2):363-74. PubMed ID: 1733508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency.
    Janssen R; Van Wengen A; Verhard E; De Boer T; Zomerdijk T; Ottenhoff TH; Van Dissel JT
    J Immunol; 2002 Oct; 169(7):3900-7. PubMed ID: 12244188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity.
    Yong EC; Chi EY; Henderson WR
    J Exp Med; 1994 Nov; 180(5):1637-48. PubMed ID: 7964451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
    Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
    Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
    Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
    J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.